Daily non-political popular news in brief.

HIV drug resistance risk in mothers reduced by combination of common drugs

11-09-2007 · EurekAlert!

Adding a single dose of two common anti-HIV drugs can prevent HIV-positive pregnant women from developing resistance to an entire class of drugs, potentially improving future treatment options.Providing tenofovir and emtricitabine with nevirapine during labor greatly reduces the extent of resistance to non-nucleoside reverse transcriptate inhibitors, such as nevirapine, which HIV-positive women take to lower the risk of mother-to-child transmission during childbirth.

Keywords: hiv, drug, resistance, risk, mothers, reduced, combination, drugs, mother

« Previous | Next »

Similar news on "HIV drug resistance risk in mothers reduced by combination of common drugs":

Drug used to prevent HIV transmission from mother to child damages DNA
04-06-2007 · EurekAlert!
HIV transmission from mother to child can occur in utero, during labor or from breastfeeding. If left untreated, approximately 25 percent of newborns exposed to the virus from their infected mothers will become infected themselves and potentially develop AIDS. Fortunately, antiretroviral drug combinations, which typically include AZT, a nucleoside reverse transcriptase inhibitor, have reduced the rate of transmission from mother to child to less than 2 percent in infants who are not breast fed.
Similar news · Read more »
Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
09-03-2007 · EurekAlert!
The largest-ever study of treatments for type 2 diabetes has shown that a combination of two blood pressure lowering drugs reduced the risk of death, as well as the risks of heart and kidney disease. The ADVANCE (Action in Diabetes and Vascular Disease) Study was led by researchers at the George Institute for International Health in Sydney and the results have been presented at the European Congress of Cardiology in Vienna.
Similar news · Read more »
NEJM report on cardiac emergency therapy finds single medication effective vs. combination drugs
11-22-2006 · EurekAlert!
A study published in the New England Journal of Medicine led by Columbia University Medical Center and New York-Presbyterian Hospital researchers showed that an anti-clotting agent called bivalirudin, when used by itself to treat acute coronary syndromes, reduced the risk of major bleeding, a key risk for mortality, by 47 percent compared with the standard combination drugs. The medication was found to be equally as effective as the combination of injectable blood thinners traditionally used.
Similar news · Read more »
Breastfeeding now safer for infants of HIV-infected mothers
02-04-2008 · EurekAlert!
An antiretroviral drug already in widespread use in the developing world to prevent the transmission of HIV from infected mothers to their newborns during childbirth has also been found to substantially cut the risk of subsequent HIV transmission during breast-feeding.
Similar news · Read more »
Drug cocktail stops brain damage caused by HIV
10-08-2007 · EurekAlert!
A combination of drugs widely used to treat infections caused by HIV appears to stop brain damage caused by the virus as well, according to a study published in the Oct. 9, 2007, issue of Neurology, the medical journal of the American Academy of Neurology.
Similar news · Read more »
Widely used hepatitis B drug spurs HIV drug resistance
02-28-2007 · EurekAlert!
A Johns Hopkins study has proven false established medical practice that an antiretroviral drug widely used to treat hepatitis B liver infections was safe to use on its own in patients co-infected with HIV. Their findings demonstrate that treatment with entecavir leads to cross-resistance to other antiviral drugs used to treat the AIDS virus.
Similar news · Read more »
Hepatitis B drug creates HIV resistance
07-14-2007 · Science News Online
A hepatitis B drug spurs resistance to HIV drugs in people infected with both diseases.
Similar news · Read more »
Experts urge strongest isolation for new drug-resistant tuberculosis cases appearing in South Africa
01-22-2007 · EurekAlert!
Medical ethics and other experts say tough isolation measures, involuntary if need be, are justified to contain a very deadly, highly-contagious and drug-resistant mutant strains of tuberculosis and to prevent "a potentially explosive international health crisis" brewing most dangerously at the epicenter of South Africa's HIV/AIDS epidemic. The new TB variations now defeat many of the world's existing drugs and pose "extreme risk."
Similar news · Read more »
Drug combo improves survival in patients with COPD
10-23-2006 · EurekAlert!
A combination of inhaled salmeterol and fluticasone propionate may reduced the risk of death in patients with chronic obstructive pulmonary disease, shows new research presented at CHEST 2006, the 72nd annual international scientific assembly of the American College of Chest Physicians.
Similar news · Read more »
Drug resistance in an influenza pandemic
01-22-2007 · EurekAlert!
Stockpiling large amounts of oseltamivir (Tamiflu) and related antiviral drugs with the intent to treat a large fraction of the population is a key part of pandemic preparedness of many countries. However, it is known that influenza viruses can develop resistance to these drugs. New research suggests that wide-spread use of antiviral drugs during a pandemic carries a substantial risk of resistance emerging and resistant influenza strains causing illness in a substantial number of people.
Similar news · Read more »